Roxbury Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Sell
3,908
-7
-0.2% -$1.8K 0.78% 37
2026
Q2
$985K Buy
3,915
+1
+0% +$215 0.78% 38
2026
Q1
$851K Buy
3,914
+345
+10% +$76.5K 0.77% 37
2025
Q4
$815K Buy
3,569
+20
+0.6% +$4.56K 0.73% 40
2025
Q3
$822K Sell
3,549
-26
-0.7% -$5.3K 0.76% 39
2025
Q2
$664K Buy
3,575
+827
+30% +$154K 0.65% 42
2025
Q1
$574K Buy
2,748
+36
+1% +$7K 0.56% 48
2024
Q4
$496K Buy
+2,712
New +$499K 0.48% 52

Other funds holding ABBV

Roxbury Financial's ABBV Position: Q3 2026 in Review

Roxbury Financial reduced its AbbVie (ABBV) stake by 0.18% in Q3 2026, selling an estimated $1.8K and leaving 3,908 shares worth $1.02M. The position accounts for 0.78% of the portfolio, ranked #37.

Roxbury Financial first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Roxbury Financial held 3,908 shares of AbbVie worth $1.02M as of Q3 2026.
  • Roxbury Financial sold 7 AbbVie shares in Q3 2026, an estimated $1.8K.
  • AbbVie made up 0.78% of Roxbury Financial's portfolio in Q3 2026, its #37 holding.
  • Roxbury Financial first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.